Velásquez-Fernández D

Language: Spanish
References: 11
Page: 32-34
PDF size: 164.95 Kb.

Text Extraction

REFERENCES

1. Kavallaris M, Marshall GM. Proteomics and disease: opportunities and challenges. Med J Aust 2005; 182: 575-9.

2. Roblick UJ. Proteomics and clinical surgery. British Journal of Surgery 2005; 92: 1464-1465.

3. Adam L, Kassouf W, Dinney CP. Clinical applications for targeted therapy in bladder cancer. Urol Clin North Am 2005; 32: 239-246.

4. You Yn. The role of prophylactic surgery in cancer prevention World J Surg 2007; 31: 450-64.

5. Skinner MA, Moley JA, Dilley WG, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005; 353: 1105-1113.

6. Miltenburg DM, Conklin L, Sastri S. The role of genetic screening and prophylactic surgery in surgical oncology. J Am Coll Surg 2000; 190: 619-628v.

7. Apple S, Hecht R, Novak JM, et al. Polymerase chain reaction based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. Am J Clin Pathol 1996; 105: 321-326.

8. Brunicardi FC. Overview of the molecular surgeon symposium on personalized genomic medicine and surgery. Access Medicine from McGraw-Hill. 2010.

9. Kathiresan S, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genet. 2008; 40: 189-197.

10. Hegele. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 2009; 10: 109-21. Epub 2009 Jan 13.

11. Pacak C. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 2007; 3: 92-102.